NU227326 |
NU227326 : Inhibitor of IDO1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| IDO1 |
|
|
Inhibitor
up to 100 nM, hook effect above this concentration
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
To define the selectivity of the lead degrader and identify any other proteins that it degrade, NU22 ...
Potency Cellular
In Vitro
IDO1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.5c00026
In Vivo Validations
Mouse
Dose: 50 mg/Kg
Route of delivery:
Intraperitoneal
Plasma half life:
5.7 h plasma, 11.8 h brain
Systemic clearance:
1.9 (mg/Kg)/uM/h plasma, 51.4 (mg/Kg)/uM/h brain
Cmax:
6.5 uM, 0.1 uM
Tmax:
0.5 h plasma/brain
Area Under the Curve::
26.9 uM*h plasma, 1.0 uM*h brain
DOI Reference: 10.1021/acs.jmedchem.5c00026
Negative Control Compounds
Chemical Information
| Molecular Formula | C53H61FN8O7 |
| SMILEs | C[C@@H](C(=O)Nc1cccc(OC2CCN(C(=O)CN3CCC(N4CCN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)CC3)CC2)c1)[C@H]1CC[C@@H](c2ccnc3ccc(F)cc32)CC1 |
| InChI | InChI=1S/C53H61FN8O7/c1-33(34-5-7-35(8-6-34)42-15-20-55-46-12-9-36(54)29-44(42)46)50(65)56-37-3-2-4-41(30-37)69-40-18-23-61(24-19-40)49(64)32-58-21-16-38(17-22-58)59-25-27-60(28-26-59)39-10-11-43-45(31-39)53(68)62(52(43)67)47-13-14-48(63)57-51(47)66/h2-4,9-12,15,20,29-31,33-35,38,40,47H,5-8,13-14,16-19,21-28,32H2,1H3,(H,56,65)(H,57,63,66)/t33-,34-,35+,47?/m1/s1 |
| Molecular weight | 940.46 Da |
| AlogP | 5.9801000000000055 |
| HBond acceptors | 15 |
| HBond donors | 2 |
| Atoms | 130 |